CamBioScience secures £400k from Henley Business Angels members to expand its AI learning platform.
The investment from Henley Business Angels members will support international scale-up and team expansion.
CamBioScience provides intensive training courses in life science technologies and operates an enterprise cloud platform for automated online learning.
CamBioScience has raised £400k in funding from members of Henley Business Angels. The capital will support the company as it scales its OBRIZUM cloud platform internationally and expands its engineering team.
The Cambridge-based firm developed OBRIZUM, a platform that uses artificial intelligence to help large enterprises in sectors such as healthcare, finance and law rapidly build and monitor adaptive online courses. Managers can deploy the software via subscription models to automate know-how transfer across global teams.
Investor perspective
"Members of HBA were really impressed by what CamBioScience have achieved and the exciting future which the investor members will help deliver."
Jurek Sikorski
Founder and Director, Henley Business Angels
Use of funds
- 01Expand into international markets
- 02Grow the team
- 03Continue product development
Investors
Categories
About the company
CamBioScience
CamBioScience develops an enterprise cloud platform that enables organisations to automatically create and deliver adaptive online training courses.